WCBA
NUVA

Weaver C. Barksdale & Associates’s NuVasive, Inc. NUVA Stock Holding History

Weaver C. Barksdale & Associates’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$6K Buy
96
+5
+5% +$284 0.01% 361
2017
Q3 		$5K Buy
91
+24
+36% +$1.59K 0.01% 379
2017
Q2 		$5K Sell
67
-10
-13% -$747 0.01% 385
2017
Q1 		$6K Hold
77
– – 0.01% 366
2016
Q4 		$5K Buy
77
+8
+12% +$516 0.01% 388
2016
Q3 		$5K Buy
+69
New +$4.39K 0.01% 388

Other funds holding NUVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Weaver C. Barksdale & Associates's NUVA Position: Q4 2017 in Review

Weaver C. Barksdale & Associates increased its NuVasive, Inc. (NUVA) stake by 5.5% in Q4 2017, buying an estimated $284 and bringing the position to 96 shares worth $6K. The position accounts for 0.01% of the portfolio, ranked #361.

Weaver C. Barksdale & Associates first reported a position in NUVA in Q3 2016 and has held it in 6 quarters since. 269 funds tracked by Wall St. Rank hold NUVA as of Q4 2017.

  • Weaver C. Barksdale & Associates held 96 shares of NuVasive, Inc. worth $6K as of Q4 2017.
  • Weaver C. Barksdale & Associates bought 5 NuVasive, Inc. shares in Q4 2017, an estimated $284.
  • NuVasive, Inc. made up 0.01% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #361 holding.
  • Weaver C. Barksdale & Associates first reported a position in NuVasive, Inc. in Q3 2016 and has held it in 6 quarters since.
  • 269 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.